Product
GZ402665
2 clinical trials
1 indication
Indication
Sphingomyelin lipidosisClinical trial
A Long-Term Study to Assess the Ongoing Safety and Efficacy of Olipudase Alfa in Patients With Acid Sphingomyelinase DeficiencyStatus: Completed, Estimated PCD: 2023-09-06
Clinical trial
A Phase 2/3, Multicenter, Randomized, Double-blinded, Placebo-controlled, Repeat-dose Study to Evaluate the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Olipudase Alfa in Patients With Acid Sphingomyelinase DeficiencyStatus: Completed, Estimated PCD: 2021-03-15